7.87

5.41% -0.45

Precision Biosciences Inc (DTIL)

Overview News Price History Option Chain Financials Discussions Forecast

Precision Biosciences Inc stock is traded at $7.87, with a volume of 287.79K. It is down -5.41% in the last 24 hours and up +21.08% over the past month. Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).

Previous Close:

$8.32

Open:

$8.17

24h Volume:

287.79K

Relative Volume:

0.72

Market Cap:

$203.06M

Revenue:

$34.26M

Net Income/Loss:

$-46.61M

P/E Ratio:

-1.5191

EPS:

-5.1806

Net Cash Flow:

$-62.01M

1W Performance:

-10.16%

1M Performance:

+21.08%

6M Performance:

+94.32%

1Y Performance:

+69.61%

1-Day Range:

$7.84

$8.35

1-Week Range:

$7.84

$8.96

52-Week Range:

$3.53

$9.62

Precision Biosciences Inc Stock (DTIL) Company Profile

Name

Precision Biosciences Inc

Sector

Healthcare (1092)

Industry

Biotechnology (603)

Phone

919-314-5512

Address

302 EAST PETTIGREW STREET, DURHAM, NC

Employee

Twitter

@PrecisionBioSci

Next Earnings Date

2026-08-06

Latest SEC Filings

DTIL's Discussions on Twitter

Compare DTIL vs VRTX, REGN, ARGX, RVMD, ALNY

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DTIL Precision Biosciences Inc	7.87	214.67M	34.26M	-46.61M	-62.01M	-5.1806
VRTX Vertex Pharmaceuticals Inc	485.65	123.36B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	676.69	71.18B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	860.55	53.68B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	186.16	38.09B	742.00K	-1.37B	-1.07B	-7.0731
ALNY Alnylam Pharmaceuticals Inc	267.47	37.80B	4.29B	577.22M	641.34M	4.2086

Precision Biosciences Inc Stock (DTIL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-10-25	Upgrade	BMO Capital Markets	Market Perform → Outperform
Apr-30-24	Initiated	Guggenheim	Buy
Jun-17-22	Initiated	BMO Capital Markets	Outperform
Jun-09-22	Downgrade	William Blair	Outperform → Mkt Perform
Jul-27-20	Resumed	BTIG Research	Buy
Apr-03-20	Downgrade	Goldman	Buy → Neutral
Mar-05-20	Initiated	Stifel	Buy
Feb-25-20	Initiated	William Blair	Outperform
Aug-09-19	Initiated	BTIG Research	Buy
Jul-16-19	Initiated	H.C. Wainwright	Buy
Apr-22-19	Initiated	Barclays	Overweight
Apr-22-19	Initiated	Goldman	Buy
Apr-22-19	Initiated	JP Morgan	Overweight
Apr-22-19	Initiated	Jefferies	Buy

View All

Precision Biosciences Inc Stock (DTIL) Latest News

Jul 15, 2026

Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)July 10, 2026 - BioSpace

Jul 10, 2026

Precision BioSciences (DTIL) Grants Inducement Awards to New Hir - GuruFocus

Jul 10, 2026

Precision BioSciences (DTIL) Short Interest & Short Float | Updated Jul 2026 $DTIL - MarketBeat

Jul 10, 2026

Jul 09, 2026

Precision BioSciences, Inc. Actuals & Estimates (TRADEGATE:PBS0) - TradingView

Jul 09, 2026

DTIL Reiterates by HC Wainwright & Co. -- Price Target Maintained at $60 - GuruFocus

Jul 09, 2026

H.C. Wainwright Maintains Precision BioSciences(DTIL.US) With Buy Rating, Maintains Target Price $60 - Moomoo

Jul 09, 2026

Jul 08, 2026

Strength Seen in Precision BioSciences (DTIL): Can Its 12.3% Jump Turn into More Strength? - Yahoo Finance

Jul 08, 2026

Jul 06, 2026

Enterprise value to revenue forward of Precision BioSciences, Inc. – NASDAQ:DTIL - TradingView

Jul 06, 2026

Jul 01, 2026

Precision BioSciences Updates Investors with Latest Corporate Deck in July 2026 SEC 8-K Filing - Minichart

Jul 01, 2026

Precision BioSciences Advances Gene-Editing Programs in Hepatitis B - TipRanks

Jul 01, 2026

Precision BioSciences (NASDAQ: DTIL) shares HBV data, DMD trial timeline - Stock Titan

Jul 01, 2026

Jun 29, 2026

Precision BioSciences, Inc.(NasdaqCM: DTIL) added to Russell 2000 Index - marketscreener.com

Jun 29, 2026

Precision BioSciences, Inc.(NasdaqCM: DTIL) added to Russell 2000 Value Benchmark - marketscreener.com

Jun 29, 2026

Precision BioSciences added to Russell 2000 index By Investing.com - Investing.com Nigeria

Jun 29, 2026

Precision BioSciences added to Russell 2000 index - Investing.com

Jun 29, 2026

Precision BioSciences (DTIL) Joins Russell 2000 Index, Highlighting Growth Potential - GuruFocus

Jun 29, 2026

Index Expanding Market Visibility with Institutional Investors - Business Wire

Jun 29, 2026

Precision BioSciences Announces Inclusion in - Moomoo

Jun 29, 2026

Jun 28, 2026

Precision BioSciences, Inc.(NasdaqCM:DTIL) added to Russell Small Cap Comp Value Benchmark - marketscreener.com

Jun 28, 2026

Precision BioSciences, Inc.(NasdaqCM: DTIL) added to Russell 2000 Dynamic Index - marketscreener.com

Jun 28, 2026

Jun 26, 2026

Precision BioSciences, Inc. Actuals & Estimates (DUS:PBS0) - TradingView

Jun 26, 2026

Price to sales forward of Precision BioSciences, Inc. – NASDAQ:DTIL - TradingView

Jun 26, 2026